Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-27

FDA Approved: OXALIPLATIN — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' Oxaliplatin as an original application generic; Oxaliplatin is a platinum-based chemotherapy used for colorectal cancer, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

ORIG AP for OXALIPLATIN (OXALIPLATIN)